{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:26:26Z","timestamp":1769811986348,"version":"3.49.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/rheumatology\/kei263","type":"journal-article","created":{"date-parts":[[2006,4,25]],"date-time":"2006-04-25T23:57:02Z","timestamp":1146009422000},"page":"913-915","source":"Crossref","is-referenced-by-count":37,"title":["Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment"],"prefix":"10.1093","volume":"45","author":[{"given":"F.","family":"Falcini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Resti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Simonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"de Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,4,25]]},"reference":[{"key":"key\n\t\t\t\t20171012110532_BIB1","doi-asserted-by":"crossref","unstructured":"Wingerchuck DM, Weinshenker BG. Neuromyelitis optica. Clinical predictors of a relapsing course and survival. Neurology2003;60:848\u201353.","DOI":"10.1212\/01.WNL.0000049912.02954.2C"},{"key":"key\n\t\t\t\t20171012110532_BIB2","doi-asserted-by":"crossref","unstructured":"Fardet L, Genereau T, Mikaeloff Y, Fontaine B, Seilhean D, Cabane J. Devic's neuromyelitis optica: study of nine cases. Acta Neurol Scand2003;108:193\u2013200.","DOI":"10.1034\/j.1600-0404.2003.02178.x"},{"key":"key\n\t\t\t\t20171012110532_BIB3","doi-asserted-by":"crossref","unstructured":"Wingerchuck DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome), Neurology1999;53:1107\u201314.","DOI":"10.1212\/WNL.53.5.1107"},{"key":"key\n\t\t\t\t20171012110532_BIB4","doi-asserted-by":"crossref","unstructured":"Gold R, Linington C. Devic's disease: bridging the gap between laboratory and clinic. Brain2002;125:1425\u20137.","DOI":"10.1093\/brain\/awf147"},{"key":"key\n\t\t\t\t20171012110532_BIB5","doi-asserted-by":"crossref","unstructured":"Davison A, Diamond B. Autoimmune diseases. N Engl J Med2001;345:340\u201350.","DOI":"10.1056\/NEJM200108023450506"},{"key":"key\n\t\t\t\t20171012110532_BIB6","doi-asserted-by":"crossref","unstructured":"Quiroz Y, Herrera-Acosta J, Johnson RJ, Rodriguez-Iturbe B. Mycophenolate mofetil treatment in conditions different from organ transplantation. Transplant Proc2002;34:2523\u20136.","DOI":"10.1016\/S0041-1345(02)03473-5"},{"key":"key\n\t\t\t\t20171012110532_BIB7","unstructured":"Ginzler EM, Aranow C, Merrill JT, Orloff K, Henry D. Toxicity and tolerability of mycophenolate mofetil (MMF) vs intravenous cyclophosphamide (IVC) in a multicenter trial as induction therapy for lupus nephritis (LN). Arthritis Rheum2003;48:S647."},{"key":"key\n\t\t\t\t20171012110532_BIB8","doi-asserted-by":"crossref","unstructured":"Ginzler EM, Aranow C. Mycophenolate mofetil in lupus nephritis. Lupus2005;14:59\u201364.","DOI":"10.1191\/0961203305lu2061oa"},{"key":"key\n\t\t\t\t20171012110532_BIB9","doi-asserted-by":"crossref","unstructured":"Mandler RN, Ahmed W, Dencoff J. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology1998;51:1219\u201320.","DOI":"10.1212\/WNL.51.4.1219"},{"key":"key\n\t\t\t\t20171012110532_BIB10","doi-asserted-by":"crossref","unstructured":"Bakker J, Metz L. Devic's neuromyelitis optica treated with intravenous gammaglobulin (IVIG). Can J Neurol Sci2004;31:265\u20137.","DOI":"10.1017\/S0317167100053932"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/45\/7\/913\/9448129\/kei263.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T05:08:31Z","timestamp":1555564111000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/rheumatology\/article\/45\/7\/913\/1788511\/Sustained-improvement-of-a-girl-affected-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,25]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2006,4,25]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/kei263","relation":{},"ISSN":["1462-0332","1462-0324"],"issn-type":[{"value":"1462-0332","type":"electronic"},{"value":"1462-0324","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7]]},"published":{"date-parts":[[2006,4,25]]}}}